Log in to search using one of your social media accounts:

 

Inovio revamps China deal; nets $23M upfront payment
Inovio Pharmaceuticals Inc. entered into an amended agreement Tueday that provides ApolloBio Corp. with the exclusive right to develop and commercialize Inovio's experimental DNA immunotherapy product in and around China. The amended deal covers the rights to Inovio's VGX-3100 product as a potential treatment for pre-cancers caused by human papillomavirus (HPV) in China, Hong Kong, Macao and Taiwan. HPV is the most common sexually transmitted infection and is the main cause of cervical cancer.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 2, 2018 Category: Biotechnology Authors: John George Source Type: news

Inovio lands $23m in collab with ApolloBio for HPV immunotherapy
Inovio Pharmaceuticals (NSDQ:INO) has inked an amended collaboration and licensing deal with ApolloBio for its DNA immunotherapy product designed to treat the pre-cancers caused by human papillomavirus. The exclusive partnership is limited to China, Hong Kong, Macao and Taiwan, but it could also include the Republic of Korea over the next three years, Inovio reported. In connection with the deal, ApolloBio is slated to pay $23 million upfront and as much as $20 million later, based on certain milestones. Get the full story at our sister site, Drug Delivery Business News. The post Inovio lands $23m in collab with Apoll...
Source: Mass Device - January 2, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Funding Roundup Oncology Pharmaceuticals Wall Street Beat Inovio Pharmaceuticals Source Type: news

HPV vaccine doesn ’t lead to unsafe sex
(Reuters Health) - - Young women who get vaccinated against the cancer-causing human papillomavirus (HPV) understand that they still need condoms to protect against other sexually transmitted infections, a U.S. study confirms. (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Understanding and Addressing the Disparity in Vaccination Coverage Among U.S. Adolescents Living in Rural Versus Urban Areas
The purpose of this notice of funding opportunity (NOFO) is to: 1) obtain a better understanding of the factors contributing to disparities in vaccination coverage observed between adolescents living in rural areas compared to adolescents living in urban areas within the United States for all recommended vaccines, with a special emphasis on human papilloma virus (HPV) vaccine; and 2) implement and evaluate an intervention(s) to improve vaccination coverage among adolescents living in rural areas. (Source: PHPartners.org)
Source: PHPartners.org - December 21, 2017 Category: International Medicine & Public Health Source Type: news

Tanzania:A Virus Responsible for Many Cancer Cases
[Citizen] There are growing concerns about the Human Papilloma Virus (HPV), a sexually transmitted virus threatening Tanzanian women. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 19, 2017 Category: African Health Source Type: news

Cervical cancer update: New research says screening should be focussed OLDER women
SCREENING for cervical cancer should be more intensively focused on women who were too old to be vaccinated against the human papillomavirus , researchers have suggested. (Source: Daily Express - Health)
Source: Daily Express - Health - December 19, 2017 Category: Consumer Health News Source Type: news

$6.6 million grant will fund UCLA-led study on how to increase use of HPV vaccine
The discovery of human papillomavirus, or HPV, as a major cause of many cancers — including cervical, anal, oropharyngeal, vaginal, vulvar and penile — and the subsequent development of prophylactic HPV vaccines was a revolution in cancer prevention.But 10 years after the vaccine ’s introduction, HPV vaccination rates among U.S. adolescents remain unacceptably low. Now, a five-year study led by UCLA cancer researcher Roshan Bastani will examine the comparative effectiveness of strategies designed to increase the number of adolescents who receive the HPV vaccine. The work i s being funded by a $6.6 million...
Source: UCLA Newsroom: Health Sciences - December 8, 2017 Category: Universities & Medical Training Source Type: news

Repeat Infection Likely for Men With HPV
Men infected with genital human papillomavirus (HPV) are at high risk for reinfection with the same type of HPV, researchers say. (Source: WebMD Health)
Source: WebMD Health - December 8, 2017 Category: Consumer Health News Source Type: news

Repeat Infection Likely for Men With HPV
FRIDAY, Dec. 8, 2017 -- Men infected with genital human papillomavirus (HPV) are at high risk for reinfection with the same type of HPV, researchers say. The investigators also found that the risk for reinfection after a year increased 20-fold for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 8, 2017 Category: General Medicine Source Type: news

Fears for women ’s health as parents reject HPV vaccine
Three nations blame social media for fall in number of girls given cervical cancer jabsHealth officials have become increasingly alarmed at campaigns aimed at blocking the take-up of the human papilloma virus (HPV) vaccine, which protects women against cervical cancer.Three leading nations have now seen major reductions in the take-up of the vaccine and a growing number of doctors fear its use could be blocked elsewhere, despite its capacity to provide protection against a condition that kills hundreds of thousands of women a year.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 3, 2017 Category: Science Authors: Robin McKie Science editor Tags: HPV vaccine Health Vaccines and immunisation Women Life and style Science Society World news Source Type: news

Is It Time to Scrap the Pap Test?
The combination of tests for cervical cancer includes a test to detect the human papillomavirus (HPV) and the test commonly known as the Pap test. (Source: WebMD Health)
Source: WebMD Health - November 27, 2017 Category: Consumer Health News Source Type: news

HPV Vaccine Could Mean 3 Pap Tests in a Lifetime HPV Vaccine Could Mean 3 Pap Tests in a Lifetime
Women who have had the human papillomavirus (HPV) jab may only need 3 smear tests for cervical cancer in their lifetime, a study suggests.WebMD Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2017 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

HPV jab means women ‘only need three smears in lifetime’
Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to UK researchers. (Source: Nursing Times)
Source: Nursing Times - November 10, 2017 Category: Nursing Source Type: news

HPV Vaccine May Prevent Rare Childhood Disease
The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease. (Source: WebMD Health)
Source: WebMD Health - November 9, 2017 Category: Consumer Health News Source Type: news

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. (Source: PHPartners.org)
Source: PHPartners.org - November 9, 2017 Category: International Medicine & Public Health Source Type: news

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
Funding for research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. (Source: PHPartners.org)
Source: PHPartners.org - November 9, 2017 Category: International Medicine & Public Health Source Type: news

HPV Vaccine Linked to Drop in Cases of Rare Childhood Disease
THURSDAY, Nov. 9, 2017 -- The human papillomavirus (HPV) vaccine, first developed to help guard against cervical cancer, also seems to protect against a rare, chronic childhood respiratory disease, a new study suggests. It's believed that the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2017 Category: General Medicine Source Type: news

HPV vaccine also prevents uncommon childhood respiratory disease, study suggests
(Infectious Diseases Society of America) The vaccine that protects against cancer-causing types of human papillomavirus (HPV) also prevents an uncommon but incurable childhood respiratory disease, according to a new study published in The Journal of Infectious Diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

HPV jab means women only need 3 cervical screens in a lifetime
(Cancer Research UK) Women may only need three cervical screens in their lifetime if they have been given the human papillomavirus (HPV) vaccine, according to a new study published in the International Journal of Cancer today. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2017 Category: Cancer & Oncology Source Type: news

Survival With HPV-related Cancers Varies by Race, Sex and Age Survival With HPV-related Cancers Varies by Race, Sex and Age
Survival with human papillomavirus (HPV)-associated cancers differs significantly between blacks and whites, men and women, and people in different age groups, according to findings from the Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries (NPCR).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

IUD May Lower Cervical Cancer Risk
TUESDAY, Nov. 7, 2017 -- IUD contraceptive devices may reduce a woman's risk of cervical cancer by about a third, a new review concludes. Researchers think IUDs might promote an immune response that kills off human papillomavirus (HPV), the virus... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 7, 2017 Category: General Medicine Source Type: news

Study reveals large disparities in survival for patients with HPV-associated cancers
(Wiley) A new study found large disparities by sex, race, and age in survival for patients diagnosed with different cancers caused by the human papillomavirus (HPV). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 6, 2017 Category: International Medicine & Public Health Source Type: news

Clarivate Analytics & Chinese Academy of Sciences announce annual report identifying 100 hottest and 43 emerging areas in global scientific research
This report reveals that based on the 143 Research Fronts, the USA is still leading global research followed by China in second place ahead of the UK and Germany. China is most prolific in chemistry, materials science, mathematics, computer science and engineering, and is leading the rest of the world in terms of research in mathematics, computer science and engineering. Twenty noteworthy topics among the 100 hottest Research Fronts are: Hot Research Fronts Field of Science Research on genome editing in plants and the utility in crops Agricultural, Plant and Animal Sciences Regulation mechan...
Source: News from STM - November 2, 2017 Category: Databases & Libraries Authors: STM Publishing News Tags: Featured World Source Type: news

HIV Guidelines Make Special HPV Recommendations for Gay Men HIV Guidelines Make Special HPV Recommendations for Gay Men
New European guidelines differ from American guidelines in that they recommend that gay and bisexual men get vaccinated for human papillomavirus until age 40.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news

For college men, low awareness of HPV risk -- Education may help increase vaccination rate
(Wolters Kluwer Health) Male collegiate athletes have high rates of risk factors for infection with the cancer-causing human papillomavirus (HPV), but have low HPV vaccination rates and low awareness of their personal health risks, according to a study in the November issue of The Nurse Practitioner, published by Wolters Kluwer. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 26, 2017 Category: Infectious Diseases Source Type: news

Medical News Today: Head and neck cancer: Could oral sex raise your risk?
Researchers have found a link between oral sex and smoking and an increased risk of a type head and neck cancer triggered by the human papillomavirus. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 21, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Men who perform oral sex on women 'more at risk of mouth and throat cancers'
Conclusion This study uses a large amount of national data to give us an idea about which groups of people have the greatest risk of carrying potentially cancer-causing oral HPV . But while oral HPV may increase people's risk of mouth and throat cancers, the actual number who would go on to develop cancer is extremely small. This study has limitations, which are worth bearing in mind: It only looked at whether people had oral HPV at a single point in time. This makes it difficult to know at what point they became infected and how much this could be down to other risk factors such as smoking, oral sex and number of partne...
Source: NHS News Feed - October 20, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Oral Sex Plus Smoking a Cancer Danger for Men
FRIDAY, Oct. 20, 2017 -- Smoking and oral sex may be a deadly combo that raises a man's risk for head and neck cancer, a new study suggests. The key factor is transmission of oral strains of the cancer-linked human papillomavirus (HPV), which can... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 20, 2017 Category: General Medicine Source Type: news

New study finds HPV vaccine to be safe for adult women
Although most human papillomavirus prevention efforts are targeted toward adolescents, a new study found the HPV vaccine is safe for adult women. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 19, 2017 Category: Consumer Health News Source Type: news

7 Million American Men Carry Cancer-Causing HPV
The incidence of mouth and throat cancers caused by the human papillomavirus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 18, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

Novan leans on its spinout, Know Bio, to bolster acne drug pipeline
Morrisville-based Novan (Nasdaq: NOVN) is broadening its focus through acquiring new intellectual property rights and is closing in on a deal to move its acne product forward. Through a deal with Know Bio – which was spun out from Novan prior to Novan’s IPO last year – Novan has acquired the exclusive worldwide rights to applications of nitric-oxide-based products for the treatment of cancer-causing viruses. Those viruses include human papillomavirus (HPV)-associa ted sexually transmitted infections. Novan… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 18, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Novan leans on its spinout, Know Bio, to bolster acne drug pipeline
Morrisville-based Novan (Nasdaq: NOVN) is broadening its focus through acquiring new intellectual property rights and is closing in on a deal to move its acne product forward. Through a deal with Know Bio – which was spun out from Novan prior to Novan’s IPO last year – Novan has acquired the exclusive worldwide rights to applications of nitric-oxide-based products for the treatment of cancer-causing viruses. Those viruses include human papillomavirus (HPV)-associa ted sexually transmitted infections. Novan… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 18, 2017 Category: American Health Authors: Jennifer Henderson Source Type: news

HPV Vaccine Safe for Adult Women: Study
WEDNESDAY, Oct. 18, 2017 -- Vaccines that ward off the cancer-linked human papillomavirus (HPV) are safe for adult women, according to a study of more than 3 million Scandinavians. The researchers, who used Danish and Swedish hospital data to track... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2017 Category: General Medicine Source Type: news

Is HPV vaccination safe for adult women?
(Wiley) In a Journal of Internal Medicine study of more than 3 million Danish and Swedish adult women, human papillomavirus (HPV) vaccination was not linked with 44 serious chronic diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2017 Category: International Medicine & Public Health Source Type: news

1 in 9 American men infected with oral HPV
Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 17, 2017 Category: Consumer Health News Source Type: news

1 in 9 U.S. Men Have Oral HPV Infection (FREE)
By Amy Orciari Herman Edited by Jaye Elizabeth Hefner, MD Nearly 12% of U.S. men are infected with oral human papillomavirus (HPV), according to an Annals of Internal Medicine study. The prevalence among women is much lower, at 3%. … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 17, 2017 Category: Primary Care Source Type: news

One in nine American men has oral HPV, study finds
About one in nine American men is infected with the oral form of human papillomavirus (HPV), according to a new study published in the journal Annals of Internal Medicine. Nationwide, rates for oral HPV infections are 11.5% of men and 3.2% of women: 11 million men, compared with 3.2 million women, the researchers estimated. (Source: CNN.com - Health)
Source: CNN.com - Health - October 16, 2017 Category: Consumer Health News Source Type: news

More men than women infected with oral human papillomavirus
(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

7 Million American Men Carry Cancer-Causing HPV Virus
The incidence of mouth and throat cancers caused by the human papilloma virus in men has now surpassed the incidence of HPV-related cervical cancers in women. (Source: NYT Health)
Source: NYT Health - October 16, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Head and Neck Cancer Human Papillomavirus (HPV) Sexually Transmitted Diseases Throat Smoking and Tobacco Men and Boys Vaccination and Immunization Infections Source Type: news

1 in 9 American Men Infected With Oral HPV
MONDAY, Oct. 16, 2017 -- Eleven million American men are infected with oral human papillomavirus (HPV), which can lead to cancers of the head, neck and throat, a new study reports. That equates to 1 in 9 U.S. males aged 18 to 69. And infection is... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 16, 2017 Category: General Medicine Source Type: news

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
Study assessed efforts among Wisconsin stakeholders in HPV vaccination and organizational capacity for future collaborative work. (Source: PHPartners.org)
Source: PHPartners.org - October 6, 2017 Category: International Medicine & Public Health Source Type: news

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015
(Source: CDC Preventing Chronic Disease)
Source: CDC Preventing Chronic Disease - October 5, 2017 Category: International Medicine & Public Health Source Type: news

HPV blood test: Throat CANCER chemotherapy treatment can cause THESE toxic side-effects
A TEST for throat cancer patients with the human papillomavirus could find whether chemotherapy treatment will be effective. (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2017 Category: Consumer Health News Source Type: news

HPV blood test: Throat cancer treatment can cause THESE toxic side-effects
A TEST for throat cancer patients with the human papillomavirus could find whether chemotherapy treatment will be effective. (Source: Daily Express - Health)
Source: Daily Express - Health - October 5, 2017 Category: Consumer Health News Source Type: news

Take a Number: The HPV Vaccine Gains Ground Among U.S. Teenagers
Sixty percent of adolescents received the vaccine in 2016. A decade ago, less than 30 percent did. (Source: NYT Health)
Source: NYT Health - September 22, 2017 Category: Consumer Health News Authors: ANERI PATTANI Tags: Human Papillomavirus (HPV) Vaccination and Immunization Centers for Disease Control and Prevention Teenagers and Adolescence Source Type: news

Transgene starts dosing in Phase Ib/II combination trial for HPV-positive cancers
Transgene has started dosing patients in a Phase Ib/II clinical trial of TG4001 in combination with avelumab to treat human papillomavirus type 16 positive (HPV-16+) recurrent or metastatic cancers. (Source: Drug Development Technology)
Source: Drug Development Technology - September 20, 2017 Category: Pharmaceuticals Source Type: news

Primary HPV Screening Detects More Lesions Than Cytology in Vaccinated Population (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Human papillomavirus (HPV) screening — compared with cytology-based screening — is associated with higher detection rates for precancerous cervical … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 20, 2017 Category: Primary Care Source Type: news

Screening for cervical abnormalities in women offered HPV vaccination
(PLOS) Human papillomavirus (HPV) testing detects a higher number of precancerous cervical lesions than cytology-based Pap smears in a female population including a proportion offered HPV vaccination, according to a new study published in PLOS Medicine by Karen Canfell of Cancer Council New South Wales, Australia, researchers at the Victorian Cytology Service, Melbourne, Australia, and colleagues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 19, 2017 Category: Cancer & Oncology Source Type: news

BU: HPV vaccine associated with improved fertility in some women
(Boston University School of Medicine) More than 40 percent of American teens are now getting vaccinated against human papillomavirus (HPV). But, despite HPV infection being associated with reduced semen quality and lower pregnancy rates, there is still public concern about whether the HPV vaccine itself could affect future fertility. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 19, 2017 Category: International Medicine & Public Health Source Type: news

Herd Immunity to HPV Emerging Among Young Women in the U.S. Herd Immunity to HPV Emerging Among Young Women in the U.S.
Human papillomavirus (HPV) infection is declining among young U.S. women, including those who have not received the vaccine, according to new research.Reuters Health Information (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news